07/27/2017 | Mark Hillen
The gene therapy era in ophthalmology edges nearer and is making RP… treatable.
Why, in terms of congresses, bigger isn't always better.
07/11/2017 | Mark Hillen
Four OCT-A devices go head-to-head. Was there a winner?
How "making light dance" can eliminate speckles from OCT scans.
Why practical hurdles help inferior drugs perform better in clinical trials than in real life.
05/31/2017 | Mark Hillen
Can an anti-VEGF agent outdo PRP for the treatment of PDR?
Collaborations, acquisitions and a potential case of misleading information…
Might the next Nobel Prize in Physiology or Medicine go to a coder, rather than a researcher or doctor?
04/06/2017 | Mark Hillen
Repeated bevacizumab injections increase the risk of glaucoma surgery.
Two approaches that could result in a better retinal implant.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: